Strategy: Actively managed by Cathie Wood's team, targeting "disruptive" innovation . Expense Ratio: 0.75% . Comparison of Key Metrics 1-Year Return Expense Ratio Small/Mid-Cap Equal Weight IBB Large-Cap Market Weighted SBIO Clinical Trial Breakthroughs IBBQ Nasdaq Biotech Index Data based on recent 2026 market reports .
Strategy: Tracks the Nasdaq Biotechnology Index at a significantly lower price point . Expense Ratio: 0.19% . best biotech etf to buy now
7 Best Biotech ETFs to Buy Now | Investing - U.S. News Money Strategy: Actively managed by Cathie Wood's team, targeting
Your (e.g., comfortable with high volatility)? Your investment timeframe ? best biotech etf to buy now
Best for: Speculative bets on high-frontier tech like gene editing and CRISPR .